Available Technologies   //   Invention Disclosure

Tech at Polsky

BACK TO SEARCH RESULTS

Tolerizing Agonist/Immunomodulator Loaded Liposomes for Long-Lived Immune Tolerance

Inventor(s):

Technology Classifications Technology Classifications > Therapeutics

    SUMMARY

    • A failure of central immune tolerance typically driven by autoantigen specific T regulatory (Treg) cells is the primary cause of many autoimmune diseases.

    • This technology generates antigen specific immune tolerance for autoimmune or transplantation therapy via induction of tolerogenic dendritic cells (tolDC, PD-L1+, CD80- CD11c+)) which facilitate the differentiation of antigen specific Tregs.

    • The invention is a liposome loaded with immunosuppressive drugs, toll-like-receptor (TLR) agonists, and any antigen of interest.  This unique co-formulation of activating and inhibitory signals generates a potent toIDC phenotype in vivo.

     

    FIGURE

    Tolerogenic Liposomes Prevent EAE Disease Progression via Antigen Specific Bystander Tolerance.
    (A) Mice were treated on day 4 and 5 (following EAE induction), allowed to rest for 48 hrs then treated again on day 7 and 8. After final treatment, mice were monitored for 37 days. (B) Mice were treated similarly, but sacrificed on day 14 following EAE induction. Serum was taken and analyzed for EAE peptide specific IgG levels via ELISA. UT denotes an “untreated” mouse without MOG exposure.

     

    ADVANTAGES

    ADVANTAGES

    • Reliable generation of antigen specific Tregs with minimal non-specific immune suppression

    • Long-lived immune tolerance

    • Easy manufacturing and storage

     

    APPLICATIONS

    • Autoimmune diseases
    • Transplant medicine

    PUBLICATIONS

    • Manuscript under review
    • In vivo experiments performed

    TECH DETAILS

    Published
    2/7/2022

    Reference ID
    22-T-003

    Have Questions?

    Michael Hinton

    Contact Michael Hinton, Manager, Technology Marketing, who can provide more detail about this technology, discuss the licensing process, and connect you with the inventor.

    This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

    Accept
    [%Analytics%]